Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis:: A comparative analysis

被引:70
作者
Fontán, MP
Rodríguez-Carmona, A
Cordido, F
García-Buela, J
机构
[1] Hosp Juan Canalejo, Serv Nefrol, Nephrol Unit, A Coruna 15006, Spain
[2] Hosp Juan Canalejo, Endocrinol Unit, A Coruna 15006, Spain
[3] Hosp Juan Canalejo, Lab Unit, A Coruna 15006, Spain
[4] Univ A Coruna, Dept Med, A Coruna, Spain
关键词
chronic renal failure; peritoneal dialysis (PD); hemodialysis (HD); leptin; insulin; insulin-like growth factor (IGF-I);
D O I
10.1016/S0272-6386(99)70038-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We performed a cross-sectional study in a wide sample of patients with chronic renal failure undergoing conservative therapy (CTh) (n = 79), peritoneal dialysis (PD) (n = 75), and hemodialysis (HD) (n = 51), with the aim of analyzing the impact of the different modes of therapy on serum leptin levels, We used a multivariate approach, taking into consideration the potential effects of other epidemiological, dialysis-related, nutritional, and hormonal factors on serum leptin. Leptin levels were higher in patients treated with PD (median, 36 ng/mL) than in those undergoing CTh (10.8 ng/mL) or HD(5.4 ng/mL) (P < 0.0005), This difference persisted after controlling for gender, body mass index, and fasting insulin levels, suggesting that imbalances in these factors may only partially explain the differences found between the three modes of therapy. Leptin levels showed a significant negative correlation with peritoneal protein losses in PD patients but were poorly associated with factors such as proteinuria, daily peritoneal glucose absorption (PD), renal function, or adequacy of dialysis, Leptin and insulin-like growth factor-I (IGF-I) were significantly correlated in PD patients, but the study design did not allow for establishing a meaning for this correlation, In conclusion, serum leptin levels are increased in PD patients when compared with CTh or HD patients. Differences in gender distribution, fat mass, and insulin levels may partially explain these findings, but other undefined factors also may have a role in producing these results, (C) 1999 by the National Kidney Foundation, Inc.
引用
收藏
页码:824 / 831
页数:8
相关论文
共 49 条
[1]  
ALASTRUE J, 1998, MED CLIN-BARCELONA, V91, P223
[2]  
BLUM WF, HORM RES S, V4, P2
[3]   Leptin and clinical medicine: A new piece in the puzzle of obesity [J].
Bray, GA ;
York, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :2771-2776
[4]   Effect of chronic metabolic acidosis on the growth hormone IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans [J].
Brungger, M ;
Hulter, HN ;
Krapf, R .
KIDNEY INTERNATIONAL, 1997, 51 (01) :216-221
[5]   Leptin: The tale of an obesity gene [J].
Caro, JF ;
Sinha, MK ;
Kolaczynski, JW ;
Zhang, PL ;
Considine, RV .
DIABETES, 1996, 45 (11) :1455-1462
[6]   Regulation of in vivo growth hormone secretion by leptin. [J].
Carro, E ;
Senaris, R ;
Considine, RV ;
Casanueva, FF ;
Dieguez, C .
ENDOCRINOLOGY, 1997, 138 (05) :2203-2206
[7]   CROSS-SECTIONAL COMPARISON OF MALNUTRITION IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS-PATIENTS [J].
CIANCIARUSO, B ;
BRUNORI, G ;
KOPPLE, JD ;
TRAVERSO, G ;
PANARELLO, G ;
ENIA, G ;
STRIPPOLI, P ;
DEVECCHI, A ;
QUERQUES, M ;
VIGLINO, G ;
VONESH, E ;
MAIORCA, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (03) :475-486
[8]   Weight regulation, leptin and growth hormone [J].
Considine, RV .
HORMONE RESEARCH, 1997, 48 :116-121
[9]   Leptin and the regulation of body weight [J].
Considine, RV ;
Caro, JF .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (11) :1255-1272
[10]   STUDY OF INSULIN-LIKE GROWTH FACTOR-I IN HUMAN OBESITY [J].
CORDIDO, F ;
CASANUEVA, FF ;
VIDAL, JI ;
DIEGUEZ, C .
HORMONE RESEARCH, 1991, 36 (5-6) :187-191